Meghna Deshraj

In this milestone 50th episode of The Healthy Enterprise, Bullzeye CEO Meghna Deshraj shares the personal journey behind building a business rooted in intention, resilience, and alignment. From leaving a stable corporate path to becoming an entrepreneur, angel investor, and global growth strategist, Meghna reflects on how marketing, healthcare, and human-centered partnership have shaped her leadership. She explains why real growth isn’t driven by louder campaigns, but by clarity, adaptation, and staying close to the people you serve. Her story captures what it truly means to be a modern growth partner—walking shoulder to shoulder with founders, helping them navigate complexity, and championing bold, meaningful progress, especially for women in business.Chapters:00:00 Celebrating Milestones: The 50th Episode02:05 Meghna's Journey: From Corporate to Entrepreneur05:47 The Evolution of Marketing: A Unique Approach12:00 Healthcare: A Personal Connection and Professional Focus18:06 Global Growth: Expanding Bullzeye's Reach24:01 The Healthy Enterprise Podcast: Bridging Gaps in Healthcare30:07 Investing in the Future: Meghna's Role as an Angel Investor35:48 Overcoming Challenges: The Power of Adaptation41:59 Final Thoughts: Embracing Change and GrowthGuest Information:Guest's Name: Meghna Deshraj Guest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/meghna-deshraj/Company / Affiliation: Bullzeye Global Growth Partners  https://bullzeyeglobal.com/Guest's Bio:  Meghna Deshraj is the Founder & CEO of Bullzeye Global Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships.Takeaways:-Meghna Deshraj is the CEO and founder of Bullzeye Global Growth Partners.-She transitioned from a corporate career to entrepreneurship through her passion for marketing.-Marketing is essential for every business, regardless of product quality.-A unique approach to marketing involves understanding client goals and needs.-Healthcare is a personal passion for Meghna, influenced by her family's background.-Global growth for Bullzeye was driven by client demand in international markets.-The Healthy Enterprise Podcast aims to bridge gaps in healthcare knowledge.-Meghna has been an angel investor for over 15 years, focusing on healthcare innovations.-Adapting and evolving are crucial for overcoming challenges in business.-Women should take bold steps and not let setbacks hold them back.The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise, Vance Clement, CEO of Lineus Medical, shares how his company is transforming the vascular access space with its innovative IV device, SafeBreak. Drawing on over 30 years in the medical device industry, Vance discusses the challenges of building a healthcare startup, navigating FDA approval, and scaling in a complex market. He also explores the evolving dynamics of hospital purchasing, the power of strategic sales and marketing, and the leadership qualities—trust, perseverance, and optimism—that drive success in medtech innovation.Chapters00:00 Introduction to Lineus Medical and Vance Clement02:55 Innovative Solutions in Vascular Access06:01 The Journey of Product Development08:49 Building a Sales Team in Medical Devices12:00 Challenges in the Medical Device Industry14:55 Navigating the Sales Cycle and Market Adoption18:11 Expanding into New Markets21:02 The Future of SafeBreak and Global Reach29:16 Exploring Market Opportunities in Medical Devices30:56 Navigating FDA Approval and Market Entry32:59 Innovations and Future Developments in Medical Devices35:10 Marketing Strategies for Medical Devices40:07 The Evolving Role of Purchasing in Healthcare43:46 Leadership Insights and Building Trust47:58 Perseverance and Optimism in EntrepreneurshipGuest Information:Guest's Name:  Vance Clement Guest's Title/Position:  CEO and Co-FounderGuest's Linkedin: https://www.linkedin.com/in/vance-clement-4378464/Company / Affiliation:  Lineus Medical https://www.lineusmed.com/Guest's Bio: Vance Clement is the CEO and Co-Founder of Lineus Medical, bringing over 30 years of experience in the medical device industry. Since joining Lineus in 2015 and becoming CEO in 2018, he has guided the company’s growth and innovation. Previously, Vance led sales and marketing at BlueInGreen, where he quadrupled annual revenue, and held senior marketing roles at Mako Surgical, helping expand the company from a small orthopedic start-up to over $100M in sales. He also spent a decade at Smith & Nephew Orthopaedics and began his career at Wright Medical Technology. Vance holds a B.S. in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University. He has been recognized as a C-Suite Leader (2021), a State Tech Leader (2022), and a Distinguished Engineering Alumni (2024).Takeaways:-Vance Clement is the CEO of Lineus Medical, focusing on vascular access solutions.-Lineus Medical's product, SafeBreak, addresses IV complications effectively.-IVs fail 46% of the time, highlighting a significant healthcare issue.-The device allows for safe separation of IV lines to prevent complications.-Vance's background includes extensive experience in medical device sales and marketing.-Building a sales team in the medical field presents unique challenges.-The sales cycle for medical devices can be long and complex.-Market adoption requires thorough product evaluations and nurse buy-in.-The veterinary market presents new opportunities for Safebrake.-Lineus Medical is expanding its reach globally, with regulatory approvals in multiple countries. -There's a significant market opportunity in medical devices.-Navigating FDA approval is a critical step for market entry.-Innovations in medical devices can lead to better patient outcomes.-Effective marketing strategies are essential for medical device companies.-Purchasing departments hold significant power in healthcare decisions.-Building trust and integrity is crucial in leadership roles.-Perseverance and optimism are key traits for entrepreneurs.-Understanding the needs of healthcare professionals can drive product success.-Engaging with top management can lead to better market penetration.-Digital marketing may not always yield immediate results in healthcare.

In this episode of The Healthy Enterprise, Bret Larsen — serial entrepreneur and CEO of Chief — shares his journey from launching his first startup in college to leading multiple high-growth B2B software companies, including the telemedicine platform E-Visit. He reflects on the lessons learned from scaling businesses, navigating the challenges of the pandemic, and transitioning from founder to CEO. Bret discusses the vision behind Chief, a predictive operations platform designed to empower sales leaders, and offers candid insights on mentorship, resilience, and the personal side of entrepreneurship.Chapters:00:00 Introduction to Brett Larson and His Journey03:03 The Birth of E-Visit and Telemedicine Innovations06:00 The Launch of Chief: A Predictive Operations Platform08:54 The Entrepreneurial Drive: Origins and Influences11:50 Navigating Challenges in Healthcare Innovation15:00 Growth During the Pandemic: A Turning Point18:09 Managing Rapid Growth and New Responsibilities20:51 Personal Growth and Leadership Development24:12 The Importance of Mentorship and Skill Evolution30:47 Unlocking Growth: The Role of Founders' Personal Lives35:50 Navigating Identity: The Founder vs. CEO Dilemma41:34 The Evolution of Chief: From Vision to Execution46:50 Building Chief: Insights from Market Research52:47 The Unique Value Proposition of Chief56:38 Passion and Pain: The Reality of Building BusinessesGuest Information:Guest's Name:Bret Larsen Guest's Title/Position:   Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/bretalarsen/Company / Affiliation: Chief  https://www.getchief.com/Guest's Bio: Bret Larsen is the Founder and CEO of Chief, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by Inc. 5000, Deloitte Fast 500, Forrester, and Gartner. Named a Titan 100 CEO, Top 50 CEO in Healthcare Technology, and Ernst & Young Entrepreneur of the Year finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education.Takeaways:Brett Larson is a three-time founder and CEO with a strong background in B2B software.His first company was a small e-commerce business started during his undergraduate studies.Brett's journey in healthcare began with E-Visit, a telemedicine platform that gained traction during the pandemic.The idea for Chief, his latest venture, was inspired by the need for predictive operations in businesses.Brett's entrepreneurial drive is influenced by his family background and early experiences in business.Healthcare is often slow to adopt technology due to the risks involved, but there are opportunities for innovation.The pandemic created a significant growth opportunity for E-Visit, leading to a 1200% increase in team size.Navigating rapid growth requires a shift in leadership skills and adaptability.Brett highlights the importance of mentorship and executive coaching in his development as a leader.The role of a CEO can be lonely, and perception plays a crucial role in leadership. You cannot increase burn for six months post-investment without proving ROI.Founders' personal lives significantly impact business success.Hiring talented individuals can be intimidating but is essential for growth.Articulating a clear vision is crucial for leadership.Goldman Sachs provides unparalleled support for startups.Recognizing feelings of languishing can lead to renewed purpose.Unlocking operational data is key to business success.The ideal customer for Chief is a VP of Sales or CRO.Pain tolerance is directly correlated to impact in business.Passion for the problem drives resilience in entrepreneurship.

In this episode, Dr. Marsha Hartman, Fractional CEO of Exodigm Biosciences, shares her journey from epidemiology to leading-edge biotech innovation. She explores how Exodigm’s breakthrough cell analysis technology is advancing personalized medicine and reshaping the future of diagnostics. The conversation dives into the lessons learned from COVID-19, the balance between science and strategy in leadership, and the ethical dimensions of AI in healthcare. Dr. Hartman also reflects on the importance of listening, collaboration, and purpose-driven work in creating meaningful impact across the life sciences.Chapters:00:00 Introduction to Marsha Hartman and Her Journey03:09 The Intersection of Epidemiology and Immunology06:00 Sales and Science: A Unique Blend09:13 COVID-19: A Case Study in Epidemiology and Immunology11:52 The Role of Biomarkers in Personalized Medicine15:02 Exodigm: Transforming Cell Analysis17:58 Marsha's Transition to CEO20:48 Leadership Philosophy and Personal Growth27:27 The Art of Listening in Leadership30:07 Lessons from COVID-19: A Global Experience34:01 The Role of Technology in Healthcare36:12 The Future of Personalized Medicine39:22 Patient Data Ownership and Accessibility42:20 The Ethical Use of AI in Healthcare44:23 Finding Your Purpose and Aligning with OthersGuest Information:Guest's Name: Dr. Marsha L. HartmanGuest's Title/Position:  Fractional CEOGuest's Linkedin: https://www.linkedin.com/in/marsha-l-hartman-phd-4b77903b/Company / Affiliation:  Exodigm Biosciences https://www.exodigm.com/Guest's Bio: Dr. Marsha L. Hartman is the Fractional CEO of Exodigm Biosciences, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.Takeaways:Marsha Hartman has a unique background in epidemiology and immunology.She transitioned from academia to sales and marketing in the life sciences.COVID-19 highlighted the importance of understanding immunology and epidemiology together.Biomarkers play a crucial role in personalized medicine and treatment outcomes.Exodime is pioneering live cell RNA analysis, which could revolutionize cell therapy.Marsha's leadership style is collaborative and focused on team success.She believes in the power of hard work, honesty, and hope in both life and science.Perfectionism can hinder authentic leadership and team dynamics.Building relationships is key to successful collaboration in science and business.Marsha's journey illustrates the importance of adaptability and continuous learning. As a leader, you must be a philosopher and a listener.Listening to your team can reveal insights you may not be aware of.COVID-19 taught us valuable lessons about collective experiences.Technology has accelerated advancements in healthcare.Personalized medicine is the future of healthcare.Patients should have ownership of their health data.AI can help eliminate biases in data interpretation.Collaboration is key to solving healthcare challenges.Understanding your purpose can guide your actions.Aligning with others can lead to greater impact.

In this episode of The Healthy Enterprise, Dr. Tia Warrick, CEO of Lesous Consulting, shares her journey in clinical research and healthcare education. She discusses the industry gaps that inspired her to launch Lesous, a company focused on bridging those divides through training, mentorship, and innovative technology. Dr. Warrick highlights the importance of practical, accessible education, the growing role of AI in clinical efficiency, and the need for equitable participation in clinical trials. With a passion for teaching and empowerment, she offers valuable insights on leadership, career growth, and creating supportive pathways for the next generation of healthcare professionals.Chapters:00:00 Introduction to Dr. Tia Warrick and Lesous Consulting03:03 Dr. Warwick's Journey in Clinical Research05:51 Identifying Gaps in Clinical Research08:59 The Role of Education and Training11:53 Leveraging AI in Clinical Research14:51 Creating Equity in Clinical Trials17:48 Innovative Training Solutions20:56 The Importance of Practical Application in Training24:11 Challenges and Rewards in Clinical Research26:51 Bridging the Gap in Healthcare Education27:16 The Journey to Teaching and Mentorship29:34 The Impact of Clinical Research30:54 Transforming Professional Development34:39 Creating a Safe Learning Environment36:37 Navigating Career Transitions39:16 Finding Your True Path43:00 Overcoming Industry Challenges48:22 Connecting with Dr. Tia WarrickGuest Information:Guest's Name:  Dr. Tia WarrickGuest's Title/Position:  Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/drwarrick/Company / Affiliation: Lesous Consulting https://lesousconsulting.com/Guest's Bio: Dr. Tia Warrick is the CEO of Lesous Consulting, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of “Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,” Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact.TakeawaysDr. Tia Warwick is the CEO of Lesous Consulting, focusing on bridging gaps in clinical research.80% of clinical trials fail due to inefficiencies and administrative bottlenecks.Education and training are crucial for improving clinical research outcomes.AI can enhance efficiency in clinical research without replacing jobs.Creating equity in clinical trials is essential for patient access to treatments.Practical application in training is more valuable than theoretical knowledge.Burnout among clinical research professionals is a significant issue.Innovative training solutions can accelerate experience and reduce mistakes.Collaboration between institutions is key to successful clinical trials.The cost of clinical trials impacts the affordability of treatments for consumers. Dr. Warrick emphasizes the need for equitable healthcare education.Teaching has always been a passion for Dr. Warrick.Clinical research plays a crucial role in patient care.Transforming professional development can lead to industry improvements.Creating a safe learning environment fosters growth.Career transitions require careful navigation and support.Finding one's true path is essential for fulfillment.Overcoming industry challenges involves positivity and resilience.A holistic approach to career coaching considers all aspects of life.Building connections and community is vital for professional success.

In this episode, Hadassah Jacobs, Founder and CEO of Hadassah Jacobs International, shares her journey as an entrepreneur and startup strategist. She discusses learning from failure, building strong systems, and her work in neuroprotection and environmental health. Hadassah also explores leadership in healthcare, the shift toward prevention, and the role of AI and marketing in creating client- and community-focused solutions.Chapters:00:00 Introduction to Hadassah Jacobs and Her Ventures03:09 The Importance of Systems in Startups06:11 Learning from Failure: The Entrepreneurial Journey09:06 Tailored Coaching for Entrepreneurs11:57 The Catalyst for Entrepreneurship: Personal Stories15:02 Innovations in Pharma: Kotzker Phfarma's Mission17:46 AgroDefense: Protecting Health and the Environment33:14 Transitioning to CEO: Challenges and Lessons Learned38:40 Navigating the Healthcare Landscape: From Intervention to Prevention46:49 Revolutionizing Healthcare Systems: A Client-Centric Approach56:16 Leadership in Entrepreneurship: Balancing Structure and FlexibilityGuest Information:Guest's Name: Hadassah JacobsGuest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/hadasjacobs/Company / Affiliation: Hadassah Jacobs International https://www.hadassahjacobs.com/ Guest's Bio: Hadassah Jacobs is the founder & CEO of Hadassah Jacobs International (HJI), a strategic launch and development studio helping visionaries turn ideas into successful ventures. With expertise in AI automation, biotech innovation, and digital strategy, she’s guided startups like Kotzker Phfarma from concept to emerging biopharmaceutical leader. Passionate about empowering women founders, Hadassah combines strategy, systems, and creativity to help entrepreneurs build impactful, scalable businesses.Takeaways:Hadassah Jacobs is the founder & CEO of Hadassah Jacobs International, a startup studio and consultancy.Systems are crucial for consistency and success in startups.Entrepreneurs often struggle with productivity and need effective systems to manage their ideas.Learning to fail fast is an essential part of the entrepreneurial journey.Tailored coaching can help entrepreneurs navigate their unique challenges.Hadassah's early experiences in entrepreneurship shaped her understanding of business.Kotzker Phfarma focuses on developing products for brain protection and neuroregeneration.AgroDefense is a product aimed at protecting civilians from environmental toxins.The importance of antioxidants in health and wellness is emphasized in Hadassah's products.Building good habits early on is vital for long-term entrepreneurial success. Transitioning to a CEO role comes with unexpected challenges.Navigating government bureaucracy can be time-consuming and frustrating.The shift from medical intervention to prevention is crucial for healthcare.Healthcare systems need to be restructured for better efficiency.Client-centric approaches are essential in healthcare.AI can enhance communication and service delivery in healthcare.Effective leadership requires balancing structure with flexibility.Planning should integrate personal and professional life for better fluidity.Marketing is key to serving and educating the community.Entrepreneurs should prioritize their well-being alongside business goal

In this episode of The Healthy Enterprise, host Michael Gorton shares his journey as a serial entrepreneur and pioneer in telemedicine through his work with Teladoc. He reflects on how COVID-19 accelerated virtual care adoption and introduces his new venture, Recuro, focused on early detection and prevention. The conversation explores innovations in mobile healthcare, AI-driven personal health data, and the future of diagnostics—while touching on the entrepreneurial mindset needed to overcome healthcare’s bureaucratic challenges and drive meaningful change.Chapters:00:00 Introduction to Michael Gorton and Telemedicine04:14 The Birth of Teladoc08:48 Telemedicine's Rise During COVID-1915:32 Transitioning to Recuro: A New Venture22:46 Innovations in Early Detection and Prevention28:28 Innovations in Mobile Healthcare31:08 The Future of Personal Health Data34:57 The Role of AI in Early Diagnosis35:41 The Journey of an Author39:10 Exploring the Universe: Plasma Physics and Beyond44:20 Phantom Space: The Future of Data Centers51:17 Overcoming Bureaucratic Hurdles in HealthcareGuest Information:Guest's Name: Michael GortonGuest's Title/Position:  FounderGuest's Linkedin: https://www.linkedin.com/in/michael-s-gorton/Company / Affiliation: Dynamic Works Consulting https://michaelgorton.us/Guest's Bio: Michael Gorton is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.Takeaways:Michael Gorton is a serial entrepreneur and founder of Teladoc.Telemedicine gained significant traction during the COVID-19 pandemic.87% of the U.S. population now prefers telemedicine for consultations.Telemedicine can be more profitable for doctors compared to traditional practices.Early detection in healthcare can prevent costly and dangerous conditions.Recuro aims to simplify healthcare and enhance early detection.The healthcare system is complicated and needs simplification.Innovative technologies can aid in early diagnosis and prevention.Access to healthcare is crucial for rural populations.Making healthcare simple can save lives and reduce costs. Mobile healthcare units are being developed for remote areas.Smartwatches can collect valuable health data.AI can help diagnose health issues early.Personal health data ownership is crucial for patients.Bureaucratic hurdles slow down healthcare innovation.Persistence is key to overcoming challenges in healthcare.Science fiction can inspire real-world innovations.Plasma physics may hold answers to extraterrestrial intelligence.Data centers in space could revolutionize AI processing.Collaboration among innovators is essential for progress.

In this episode of The Healthy Enterprise, Heath sits down with Michele Hart, Director of Marketing Communications at BostonSight, to explore the art and impact of nonprofit marketing in healthcare. Michele shares her journey from anthropology and journalism to leading marketing for a pioneering organization improving lives through innovative scleral lens technology. She discusses the challenges of mission-driven marketing—balancing purpose with growth, navigating the pandemic’s disruption, and aligning teams across marketing, sales, and product development—while emphasizing the importance of clear communication, the value of outsourcing for fresh perspectives, and the strategies that have helped BostonSight strengthen its brand and expand its global reach.Chapters:00:00 Introduction to Michele Hart and Her Journey02:52 Transitioning to Nonprofit Marketing05:54 The Impact of COVID-19 on Work Dynamics08:55 Understanding BostonSight and Its Mission11:50 The Science Behind Scleral Lenses14:59 Marketing Challenges and Strategies at BostonSight17:52 Navigating the Commercial Landscape of Scleral Lenses21:01 Expanding Global Reach and Partnerships23:58 Optimizing Marketing Channels and Strategies26:23 Streamlining Communication in Marketing30:31 The Importance of Outsourcing for Fresh Perspectives34:40 Aligning Marketing, Sales, and Product Development36:53 Revenue Generation in Nonprofits38:40 Innovative Marketing Strategies and Patient Engagement42:25 The Future of Marketing: Balancing Digital and In-Person45:45 Innovations in Scleral Lens TechnologyGuest Information:Guest's Name: Michele HartGuest's Title/Position:  Director, Marketing and Communications Guest's Linkedin: https://www.linkedin.com/in/michelespilberghart/Company / Affiliation:BostonSight https://www.bostonsight.org/Guest's Bio: Michele Hart is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including The New York Times, The Boston Globe, Good Housekeeping, TIME, and Prevention Magazine.Takeaways:Michele Hart has over 25 years of experience in healthcare marketing.Her background in anthropology has been valuable in understanding consumer behavior.Transitioning to nonprofit work has provided her with meaningful mission-based experiences.COVID-19 created unique challenges but also fostered team bonding.BostonSight specializes in scleral lenses that improve vision and comfort for patients.The organization has a strong focus on patient care and research.Marketing strategies include optimizing channels and building brand identity.The commercial scleral lens is used by optometrists worldwide.Partnerships with international eye institutes have expanded their reach.Press releases remain a vital tool for internal communication and marketing. Streamlining communication is essential to avoid muddled messaging.Outsourcing can provide valuable insights and an objective perspective.Aligning marketing, sales, and product development is crucial for success.Nonprofits must focus on revenue generation to sustain their mission.Innovative marketing strategies can enhance patient engagement.In-person connections are becoming increasingly important post-pandemic.Traditional marketing methods are seeing a resurgence in the digital age.Scleral lenses are evolving with new technology for better patient outcomes.A focus on prevention in healthcare could transform patient care.Engaging with patients through webinars and testimonials builds trust. 

In this episode of The Healthy Enterprise, host Heath speaks with Ataes Aggarwal, co-founder of Moodr Health, an AI-driven platform improving behavioral health through remote monitoring. They discuss Moodr’s origins, its evolution from perinatal mental health to broader applications, and the ethical use of AI in healthcare. Ataes shares lessons on scaling a health tech startup, building motivated and independent teams, and navigating challenges unique to communities like Appalachia. The conversation also touches on marketing’s role in brand growth, the power of partnerships, and Ataes’ core advice: keep things simple and stay persistent.Chapters:00:00 Introduction to Moodr Health and Its Mission03:12 The Genesis of Moodr Health06:09 The Role of Data in Behavioral Health08:46 Building Relationships Through Technology12:07 Ethical AI in Healthcare15:00 Expanding Focus: From Perinatal to Broader Mental Health18:06 Challenges and Growth in Business21:04 Real-World Impact and Case Studies24:02 Scalability and Future Directions28:15 Motivation and Team Dynamics32:24 Marketing and Brand Development37:30 Scaling Challenges and Team Independence40:46 Community Impact and Healthcare Challenges45:05 Collaborations and Partnerships48:04 Final Thoughts and AdviceGuest Information:Guest's Name: Ataes AggarwalGuest's Title/Position:  Co-FounderGuest's Linkedin: https://www.linkedin.com/in/ataes/Company / Affiliation: Moodr Health  https://moodrhealth.com/Guest's Bio: Ataes Aggarwal is the co-founder of Moodr Health, a company empowering healthcare organizations to build genuine, scalable connections with their patients through AI-driven, ethical technology. A Johns Hopkins Biomedical Engineering graduate, Ataes combines technical expertise with empathy to advance behavioral health. He champions responsible AI, emphasizing privacy, fairness, and respect, and believes success comes from simplicity, perseverance, and creating real impact in people’s lives.Takeaways:Moodr Health aims to stop silent suffering in behavioral health.The platform started with a psychiatrist using Fitbits for patient data.Data collection in mental health can enhance treatment efficacy.Building relationships through technology is key to patient care.Ethical AI is crucial in healthcare applications.Moodr Health is expanding its focus beyond perinatal mental health.The company is passionate about serving veterans and community health.Scalability is a challenge but the technology is designed for growth.Real-time data can improve patient-provider communication.The team is dedicated to making a meaningful impact in healthcare. Motivation stems from having a clear vision and a supportive team.A strong team is essential for navigating the challenges of a startup.Continuous learning is crucial, often through traditional methods like textbooks.Marketing is a vital component of a startup's success.Founders often have a deep connection to their brand and its story.Building independence within teams is key to scaling effectively.Healthcare challenges in Appalachia require innovative solutions.Collaborations with organizations can enhance service delivery.Every detail matters when serving patients and customers.Simplicity in communication and strategy is difficult but essential.

In this conversation, Michael Friend, Founder and CEO of the Minority Coalition for Precision Medicine, discusses the critical role of precision medicine and CRISPR technology in addressing health disparities, particularly in minority communities. He shares his personal journey, the challenges faced by individuals with sickle cell disease, and the importance of building trust in healthcare. The conversation emphasizes the need for community engagement, youth involvement, and advocacy to drive change in the healthcare landscape.Chapters:00:00 Introduction to Precision Medicine and CRISPR03:00 Understanding Sickle Cell Disease and Its Challenges06:00 The Role of CRISPR in Healthcare09:02 The Importance of Trust in Healthcare for Minorities11:59 The Coalition's Mission and Community Engagement14:56 Overcoming Skepticism Around Precision Medicine18:01 The Tipping Point for CRISPR and Public Awareness21:12 Future of Precision Medicine and Business Models23:49 Advocacy and Personal Motivation27:03 Engaging Youth in Healthcare Conversations30:05 Advice for Aspiring Change-Makers33:11 Conclusion and Future OutlookGuest Information:Guest's Name: Michael FriendGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/michael-friend-/Company / Affiliation: Minority Coalition for Precision MedicineGuest's Bio: Michael Friend is a U.S. veteran and founder of the Minority Coalition for Precision Medicine (MCPM), dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.Takeaways:Michael Friend is the CEO of the Minority Coalition for Precision Medicine.The coalition aims to reduce health disparities in minority communities.Sickle cell disease is a painful and complex condition.CRISPR technology has the potential to reshape healthcare.Building trust in healthcare is crucial for minority communities.Community engagement is essential for awareness and education.Skepticism around precision medicine exists but is changing.Youth involvement is vital for the future of healthcare.Private-public partnerships are necessary for innovation.Advocacy and personal motivation drive change in healthcare.

In this episode of The Healthy Enterprise, Trace Voshell, Chief Revenue Officer at GoGoMeds, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees.Chapters:00:00 Introduction to GoGoMeds and Trace's Journey02:57 Understanding Pharmacy Operations and Patient Care05:54 The Challenges of Healthcare Costs09:02 Innovations in Medication Access and Employer Benefits11:52 Telemedicine and Custom Pharmacy Solutions14:49 Transitioning to GoGoMeds and Leadership Style24:03 The Drive to Win: A Personal Philosophy25:04 Documentary Insights: Uncovering Healthcare Costs28:07 Marketing Strategies: Outsourcing for Growth32:18 Sales Team Dynamics: Growth and Strategy34:32 The Balance of Aggression and Patience in Sales38:03 Building a Winning Corporate Culture43:13 AI in Business: Balancing Automation and Personal Touch45:13 Final Thoughts and Future ConnectionsGuest Information:Guest's Name:Trace VoshellGuest's Title/Position: Chief Revenue OfficerGuest's Linkedin: https://www.linkedin.com/in/trace-voshell-34040b7a/Company / Affiliation: GoGoMeds https://gogomeds.com/GoGoClient/homeGuest's Bio: Trace Voshell is the Chief Revenue Officer of GoGoMeds, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first.Takeaways:Trace Bushell transitioned from a baseball career to pharmacy.GoGoMeds aims to transform patient access to medications.Healthcare costs can be overwhelming for patients.GoGoMeds offers significant savings on generic medications.Employers can benefit from offering $0 medications to employees.Telemedicine is a growing area for GoGoMeds.Custom pharmacy solutions enhance patient care.Trace's personal experience with cancer informs his work.Leadership involves being hands-on and empathetic.Failures are part of the journey to success.  I like to win, don't care about recognition.The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.Go Go Meds is a solution in the pharmacy space.I was one of the producers of the documentary.We needed to enhance our marketing efforts.You can't just have one marketing piece for all verticals.Aggression and patience are key in sales.Culture is crucial for employee motivation.You have to remain a person in sales interactions.We're changing the pharmacy landscape for affordability.

In this heartfelt conversation, Raymond Rodriguez-Torres shares his journey as the CEO of ALC Home Health and the founder of the Live Like Bella Foundation, which supports families affected by childhood cancer. He recounts the challenges faced when his daughter Bella was diagnosed with cancer and how her spirit inspired a movement to help others. The discussion highlights the foundation's significant contributions to pediatric cancer research and the support services it provides to families in need. In this conversation, Raymond shares his journey of turning personal tragedy into a mission to help others through the Live Like Bella organization. He emphasizes the importance of living joyfully and fearlessly, serving others during difficult times, and the critical need for accurate data in pediatric cancer research. The discussion also highlights innovations in treatment and the transition to home health care, along with valuable leadership lessons about trust and purpose in work.Chapters:00:00 Introduction to Raymond Rodriguez-Torres and His Journey02:21 The Impact of Bella's Illness on Family and Community07:12 Navigating Professional Life Amidst Personal Crisis11:37 The Mission and Achievements of Live Like Bella Foundation16:31 In-Treatment and Memorial Support Services23:36 Living Like Bella: A Legacy of Joy and Fearlessness25:05 Facing Tragedy: Finding Purpose in Adversity25:42 The State of Pediatric Cancer: Data and Awareness29:06 The Importance of Accurate Data in Childhood Cancer32:08 Innovations in Pediatric Cancer Research36:36 Transitioning to Home Health Care: A Personal Journey41:11 Leadership Lessons: Trust and Purpose in WorkGuest Information:Guest's Name: Raymond Rodriguez-TorresGuest's Title/Position: ChairmanGuest's Linkedin: https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/Company / Affiliation:  Live Like Bella® Foundation  https://livelikebella.org/ Guest's Bio: Raymond Rodriguez-Torres is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk Tragedy to Triumph: Live Like Bella ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the Live Like Bella® Foundation, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis.Takeaways:Raymond Rodriguez-Torres is the CEO of ALC Home Health and founder of Live Like Bella.The Live Like Bella Foundation has raised over $40 million for childhood cancer research.Bella's illness led to the creation of a movement focused on serving others.The foundation provides financial support for families dealing with childhood cancer.Live Like Bella funds pediatric cancer research through innovative state funding initiatives.The organization pays bills directly to avoid tax implications for families.Memorial support is offered for families who have lost children to cancer.Raymond emphasizes the importance of community support during crises.The foundation operates in 38 countries, providing global assistance.Raymond believes that Bella's life was a gift that continues to inspire others. Live like Bella as a guiding principle in life.Serving others can provide strength during adversity.Finding a purpose can help answer the question of why.Accurate data is crucial in understanding childhood cancer.Childhood cancer should be treated as a chronic illness.Innovative research is leading to breakthroughs in pediatric oncology.Home health care offers better comfort for patients.Trust is essential in leadership and team dynamics.Passion in work leads to fulfillment and success.Every child deserves a chance to fight cancer at home.

In this episode, Laura Lampa, CEO of LML StoryLab Consulting, shares her journey from a scientist to a communication expert in the life sciences sector. She discusses the importance of effective communication in science, her transition to entrepreneurship, and the challenges of being a solopreneur. Laura emphasizes the significance of networking, leveraging AI in her work, and maintaining a work-life balance. She also provides valuable advice for aspiring entrepreneurs and shares her vision for the future of her business.Chapters:00:00 Introduction to Laura Lampa and LML StoryLab02:54 Journey from Science to Communication05:55 The Transition to Entrepreneurship09:02 Challenges of Solopreneurship12:01 Networking and Building Relationships15:00 Vision for the Future of LML StoryLab18:11 Leveraging AI in Communication20:57 Advice for Aspiring Entrepreneurs23:54 Conclusion and Key TakeawaysGuest Information:Guest's Name:Laura Lampa Guest's Title/Position: Founder and CEOGuest's Linkedin: https://www.linkedin.com/in/lauralampa/Company / Affiliation: LML StoryLab Consulting https://lmlstorylab.com/homeGuest's Bio: Laura Lampa is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.Takeaways:Laura Lampa transitioned from a scientist to a communication expert.Effective communication can unlock conversations and connections.Networking is crucial for building relationships and finding clients.AI can be a strategic partner in writing and communication.Time management is a significant challenge for solopreneurs.Maintaining professional connections helps avoid loneliness.It's important to know your limits as a solopreneur.You can develop tools and templates for clients to use independently.Showing up consistently builds credibility and trust.Entrepreneurship requires a willingness to take risks and embrace challenges.

In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field.Chapters00:00 Introduction to Cell and Gene Therapy Innovations03:04 Exploring Vector Technology and Its Applications05:59 Brian Newsom's Journey: From Science to Business09:08 Leveraging AI and Technology in Biotech11:59 Navigating Fundraising Challenges in Biotech14:49 Strategic Partnerships and Market Positioning22:12 Building Long-Term Relationships in Healthcare23:27 Leadership Style and Team Dynamics26:00 The Challenges of Foundership28:32 Finding Inspiration and Motivation31:12 The Intersection of Science Fiction and Reality33:03 Future Trends in Healthcare35:34 Advice for Aspiring Professionals37:17 Navigating Tough Times in the IndustryGuest Information:Guest's Name: Brian NewsomGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brian-newsom/Company / Affiliation:  Carrigent https://carrigent.com/Guest's Bio: Brian Newsom is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&M University.Takeaways:Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.Carrigent is developing a next-generation payload delivery system.The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.Brian transitioned from a scientific role to business development to have a broader impact.AI is being leveraged to create efficiencies in biotech operations.Fundraising in biotech is currently challenging due to market conditions.Strategic partnerships are essential for asset development and exposure.The ultimate goal is to partner with pharma and biotech for therapeutic development.Brian's diverse background provides a unique perspective in the industry.The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.Leadership involves trusting your team to do their jobs.Founders often struggle to let go of their vision.Inspiration can come from various sources, including literature.Science fiction often predicts future scientific advancements.Early diagnostics are essential for effective treatment.The healthcare industry is evolving with new therapies.Resilience is key in navigating industry challenges.Patient care should be the primary motivation for professionals.The future of healthcare will focus on curing chronic diseases.

In this episode of The Healthy Enterprise, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact.Chapters:00:00 Introduction to Envoy Medical and Brent Lucas01:01 Brent's Journey in the Hearing Loss Industry05:03 Transforming Envoy Medical's Product Line09:04 The Impact of Cochlear Implants on Quality of Life13:01 Navigating Clinical Trials and Market Readiness15:10 Transitioning from Lawyer to CEO18:03 Leadership Challenges and Personal Management22:07 Family Influence and Entrepreneurial Spirit23:35 Going Public: A Strategic Decision24:24 Navigating the Public Market: Opportunities and Challenges27:39 Community Impact: Building Jobs and Relationships30:10 Leadership Lessons: From Sports to Business33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome36:19 Innovating with Technology: The Future of Medical Devices41:41 Marketing Strategy: Organic Growth Through Patient StoriesGuest Information:Guest's Name: Brent LucasGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brent-lucas-envoy/Company / Affiliation: Envoy Medical https://www.envoymedical.com/Guest's Bio: Brent  Lucas is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.Takeaways:Envoy Medical is a 30-year-old startup focused on hearing loss solutions.Brent Lucas became CEO during a pivotal transformation of the company.The company specializes in fully implanted hearing devices without external components.Cochlear implants can greatly enhance the quality of life for users.Navigating clinical trials is a lengthy but necessary process for product launch.Brent transitioned from a legal background to a leadership role in a medical device company.Effective communication is crucial for leadership success.Family influence played a significant role in Brent's entrepreneurial journey.The decision to go public was strategic for the company's growth.Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.Community engagement is crucial for company culture and job creation.Leadership lessons can be learned from unexpected places, like sports.Imposter syndrome is a common challenge for leaders.Innovating with technology is essential in the medical device industry.Patient demand for fully implanted devices is expected to be high.Organic marketing through patient stories can be powerful.The transition to public markets comes with both opportunities and challenges.Maintaining focus on core products is vital for success.The surgical process for the new device is outpatient and efficient.

In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry.Chapters:00:00 Introduction to Salve Therapeutics and Patient Empowerment02:58 The Role of Technology in Drug Development06:00 Innovative Software Solutions for Rare Diseases08:58 Patient Self-Management and Mobile Health Apps12:06 Collaboration and Mentorship in Biotech14:56 Real-Time Health Data and Patient Engagement26:23 The Journey of App Development31:01 Navigating Fundraising and Investor Relations37:17 Transitioning from Founder to CEO44:30 The Importance of Thoughtfulness in LeadershipGuest Information:Guest's Name: Stefan LukianovGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/Company / Affiliation:  Salve Therapeutics https://www.salvetherapeutics.com/Guest's Bio: Stefan Lukianov is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.Takeaways:Stefan Lukianov is the founder and CEO of Salve Therapeutics.Salve Therapeutics focuses on patient empowerment through technology.The company aims to reduce the cost of drug development for rare diseases.Their software is designed for drug developers to streamline the process.Real-time health data is crucial for patient engagement.Collaboration and mentorship are key in the biotech field.Mobile health apps can enhance patient self-management.The goal is to make healthcare more accessible and efficient.Patient independence is a priority in healthcare innovation.Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.It's important to attract users with the app's design and functionality.Fundraising is a complex process that requires careful planning.Transitioning from founder to CEO involves balancing vision with operational realities.Thoughtfulness in decision-making leads to better outcomes.Listening to feedback is crucial for growth as a founder and CEO.Building relationships with potential customers is key to success.The healthcare app industry is heavily regulated, making development challenging.Networking and attending events can lead to valuable connections.Having a clear vision helps in managing investor expectations.

In this episode, Marc Koska shares his journey as a social entrepreneur and healthcare innovator. He discusses creating the K1 auto-disabled syringe, which has saved millions of lives by preventing the spread of blood-borne diseases, and his transition to Apiject to advance healthcare delivery with new injection technologies. Marc also reflects on lessons from biomimicry and product design, the challenges of global health in developing countries, and the importance of firsthand experience, social awareness, and data-driven decision-making in driving meaningful innovation.Chapters:00:00 Introduction to Marc Koska and His Innovations05:03 The Birth of the K1 Auto-Disabled Syringe12:09 Impact of the K1 Syringe on Global Health17:50 Transition to Apiject and New Innovations25:03 Future of Healthcare and Injection Devices26:59 Empowerment Through Creation29:20 The Birth of Biomimicry32:12 Social Impact and Empowerment35:24 Innovations in Design and Technology39:35 The Journey of Social Entrepreneurship45:55 Advice for Aspiring InnovatorsGuest Information:Guest's Name: Marc KoskaGuest's Title/Position: Co-founder and Head of Production DesignGuest's Linkedin: https://www.linkedin.com/in/marc-koska-5761181a/Company / Affiliation: ApiJect https://apiject.com/Guest's Bio: The inventor of the Apiject Platform and its first BFS injection device is Marc Koska, a highly honored “social entrepreneur.” The Prefilled Apiject Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading Apiject R&D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of Apiject’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The Apiject Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives.Takeaways:Marc Koska invented the K1 auto-disabled syringe to prevent disease spread.The K1 syringe has saved approximately 12 million lives.Syringe reuse was a major transmission route for HIV.Marc's journey involved extensive research and learning about syringes.The K1 syringe design was a significant innovation in healthcare.Marc's work has had a profound impact on global health education.Apiject aims to provide safer and more accessible injection devices.The new injection devices are designed for self-administration.Environmental concerns are addressed with new syringe designs.Marc's career reflects a commitment to solving large-scale health problems. Empowerment comes from creating impactful solutions.Biomimicry is a study of nature's designs and interactions.Social entrepreneurship requires understanding the core truth of problems.Technology, like AI and 3D printing, enhances design processes.Traveling and seeing problems firsthand is crucial for entrepreneurs.Data and understanding all viewpoints are essential for success.Innovative design must consider social implications.Creating a supportive team culture is vital for success.Challenging the status quo is necessary for meaningful change.Success in social entrepreneurship requires a combination of passion and practicality.

In this episode of The Healthy Enterprise Podcast, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs.Chapters:00:00 Introduction to Biodesign Innovation Labs02:47 Innovative Medical Devices for Critical Care05:50 AI and Precision Medicine in Cancer Care08:48 The Journey of Entrepreneurship in Healthcare12:05 Personal Experiences Shaping Innovation14:56 Building a Team and Community Engagement17:51 The Role of Mentorship and Collaboration21:07 Navigating the Healthcare Ecosystem23:56 Advice for Aspiring Innovators29:21 Journey into Medical Device Innovation32:53 Overcoming Personal Tragedy and Professional Challenges35:46 The Importance of Team Dynamics in Medical Innovation39:28 Leadership Lessons from Personal Loss44:37 Future Aspirations in Cancer Treatment and AI48:19 Advice for Aspiring EntrepreneursGuest Information:Guest's Name: Gautham PasupuletiGuest's Title/Position: Co Founder & CEOGuest's Linkedin:https://www.linkedin.com/in/gautham-pasupuleti-84884054/Company / Affiliation: Biodesign Innovation Labs https://biodesigninnovationlabs.com/Guest's Bio: Gautham Pasupuleti is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.Takeaways:Biodesign Innovation Labs focuses on life-saving medical devices.Respirate is an automated solution for manual ventilation.The company started its journey in 2017 with a focus on critical care.Personal experiences can drive innovation in healthcare.Community engagement is crucial for understanding healthcare needs.Mentorship plays a significant role in entrepreneurial success.AI solutions are being developed for early cancer detection.Building a team with diverse skills is essential for success.Hands-on experience is vital for understanding real-world problems.Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.He collaborated on a VR and AR device for children's eye exams.After his brother's passing, he took on significant responsibilities in their startup.The importance of innovation in medical devices cannot be overstated.Team dynamics and diverse skill sets are crucial for success.Personal experiences can drive motivation to solve meaningful problems.Leadership requires making tough decisions and trusting your instincts.Gautham learned valuable lessons from his brother's mentorship.Resilience and persistence are key traits for entrepreneurs.Networking with experienced individuals can provide valuable insights. 

In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals.Chapters:00:00 Introduction to AI in Healthcare03:49 The Genesis of CureMetrix09:10 Challenges in Mammography14:58 Innovations in Breast Cancer Detection21:10 Leadership and Team Dynamics at CureMetrix26:19 Building a Professional Culture27:37 Challenges in AI Adoption31:24 Navigating Regulatory Hurdles34:40 Sales Strategies in a Niche Market39:02 AI's Role in Women's Healthcare42:04 Opportunities in Healthcare CareersGuest Information:Guest's Name: Kevin HarrisGuest's Title/Position: President and co-founder Guest's Linkedin: https://www.linkedin.com/in/kevindavidharris/Company / Affiliation: CureMetrix https://curemetrix.com/Guest's Bio: Kevin Harris is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.Takeaways:Kevin Harris has over 35 years of experience in technology.CureMetrix was founded to leverage AI in healthcare.The company focuses on improving mammography outcomes.Breast arterial calcifications can indicate serious health issues.AI can help reduce false positives in mammography.CureMetrix's software provides valuable insights to radiologists.Collaboration with data scientists is crucial for innovation.Building a strong team and mentorship is key to success.Understanding the healthcare landscape is essential for leaders.Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.AI is perceived as a tool rather than a replacement for doctors.AI operates consistently without human limitations.Regulatory challenges are significant in bringing AI to market.Sales strategies must target the right decision-makers in healthcare.Education is crucial for the adoption of AI in healthcare.AI can help radiologists focus on more critical cases.There are opportunities to automate certain healthcare tasks safely.AI can assist in pre-reading medical images to save time.The healthcare system needs to improve public education on health issues.

In this episode of The Healthy Enterprise, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care.Chapters:00:00 Introduction to Oncoscope-AI and Anna Forsythe03:04 The Need for Real-Time Oncology Data05:59 Transitioning from Manual to Automated Data Processing09:11 The Role of AI in Oncology12:13 Feedback and Response from Healthcare Professionals14:45 Data Sources and Systematic Reviews in Oncology18:02 Future Developments and Expanding Services21:53 AI in Research: Balancing Trust and Efficiency25:52 Business Model and Revenue Streams29:44 Personal Journey and Altruism in Business32:56 Challenges and Opportunities in Healthcare35:34 Leadership and Team Dynamics39:29 Visionary Leadership and Future AspirationsGuest Information:Guest's Name: Anna ForsytheGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/anna-forsythe-3667143/ Company / Affiliation:  Oncoscope-AI https://oncoscope-ai.com/ Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 JAMA Pediatrics article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.Takeaways:Anna Forsythe is the founder and CEO of Oncoscope AI.Oncoscope AI provides real-time oncology treatment data and clinical guidelines.Doctors are overwhelmed with the volume of new evidence and guidelines.The platform aims to simplify access to oncology data, similar to Expedia for travel.AI is used to automate data processing but has limitations in consistency and accuracy.The platform is currently free for doctors to encourage adoption.Feedback from healthcare professionals is shaping the development of the platform.Data is sourced from publicly available databases like PubMed and clinical trials.The platform is expanding to include more cancer types and features.The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.A standardized database enhances research efficiency.The business model aims for profit while providing value.Personal experiences shape the desire to help others.Gathering data from doctors can lead to significant advertising revenue.The speaker is focused on launching multiple cancer treatments.Trust and transparency are crucial in AI innovation.Working with young talent is fulfilling and beneficial.Challenges in scaling the business are common in startups.Visionary leadership requires prioritization and focus.